Johnson Midwest Financial’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Johnson Midwest Financial’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-300	Closed	-$7.23K	–	396
2023 Q1	$7.23K	Buy	+300	New	+$3.77K	0.01%	234

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Johnson Midwest Financial's PRVB Position: Q2 2023 in Review

Johnson Midwest Financial sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 300 shares — an estimated $7.23K sold.

Johnson Midwest Financial first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $7.23K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Johnson Midwest Financial reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Johnson Midwest Financial sold 300 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $7.23K.
Johnson Midwest Financial first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Johnson Midwest Financial's Provention Bio, Inc. Common Stock position peaked at $7.23K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Johnson Midwest Financial's 13F filing for Q2 2023, filed 20 Jul 2023.